Journal Articles
Disclaimer: The papers below are intended for private viewing by the page owner or those who otherwise have legitimate access to them. No part of it may in any form or by any electronic, mechanical, photocopying, recording, or any other means be reproduced, stored in a retrieval system or be broadcast or transmitted without the prior permission of the respective publishers. If your organization has a valid subscription of the journals, click on the DOI link for the legitimate copy of the papers.
View By Year Published
2014-2015
Li Z, Pergolizzi JV, Huttner RP, Zampogna G, Breve F, Raffa RB
Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs J Clin Pharm Ther. 2015 Dec;40(6):615-9
Nguyen V, Raffa RB, Taylor R, Pergolizzi JV Jr
The role of abuse-deterrent formulations in countering opioid misuse and abuse J Clin Pharm Ther. 2015 Dec;40(6):629-34
Meissner W, Coluzzi F, Fletcher D, Huygen F, Morlion B, Neugebauer E, Pérez AM, Pergolizzi J.
Improving the management of post-operative acute pain: priorities for change Curr Med Res Opin. 2015 Nov;31(11):2131-43
DOI:10.1185/03007995.2015.1092122
Coluzzi F, Mattia C, Savoia G, Clemenzi P, Melotti R, Raffa RB, Pergolizzi JV Jr.
Postoperative Pain Surveys in Italy from 2006 and 2012: (POPSI and POPSI-2) Eur Rev Med Pharmacol Sci. 2015 Nov;19(22):4261-9.
Pergolizzi JV, Köknel Talu G, Zmponga G, Erdine S, Taylor R, Ayan B, Raffa RB
Maximizing value in opioid utilization: Is oxycodone immediate release a good option for pain management? Agri. 2015;27(1):1-11
Pergolizzi JV Jr.
New care measures and their impact on pain medicine: One pain specialist’s perspective Postgrad Med. 2015 Aug;127(6):616-22.
DOI:10.1080/00325481.2015.1054616
Nalamachu SR, Pergolizzi J, Taylor R Jr, Slatkin NE, Barrett AC, Yu J, Bortey E, Paterson C, Forbes WP
Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials Pain Pract. 2015 Jul;15(6):564-71
Pergolizzi JV Jr, Scholten W, Smith KJ, Leighton-Scott J, Willis JC, Henningfield JE.
The unique role of transdermal buprenorphine in the global chronic pain epidemic. Acta Anaesthesiol Taiwan. 2015 Jun;53(2):71-6.
Pergolizzi JV Jr, Taylor R Jr, Raffa RB.
The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain Adv Ther. 2015 Jun;32(6):485-95
Eichenbaum G, Göhler K, Etropolski M, Steigerwald I, Pergolizzi J, Kim M, Vorsanger G
Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency J Opioid Manag. 2015 May-Jun;11(3):211-27
Coluzzi F, Raffa RB, Pergolizzi J, Rocco A, Locarini P, Cenfra N, Cimino G, Mattia C.
Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease. J Pain Res. 2015 May 8;8:229-38
Yarlas A, Miller K, Wen W, Lynch SY, Munera C, Dain B, Pergolizzi JV Jr, Raffa R, Ripa SR
A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with Depression. Pain Pract. 2015 Apr 11
Pergolizzi JV Jr, Taylor R Jr, Raffa RB
Intranasal ketorolac as part of a multimodal approach to postoperative pain. Pain Pract. 2015 Apr; 15(4):378-88
Coluzzi F, Pergolizzi J, Raffa RB, Mattia C
The unsolved case of “bone-impairing analgesics”: the endocrine effects of opioids on bone metabolism Ther Clin Risk Manag. 2015 Mar 31; 11:515-23
Pergolizzi JV Jr, Zampogna G, Taylor R Jr, Raffa RB
Long-term efficacy, safety and tolerability of Remoxy for the management of chronic pain. Expert Rev Neurother. 2015 Mar; 15(3):231-8
DOI:10.1586/14737175.2015.1015418
Pergolizzi JV Jr.
DEA reschedules hydrocodone combination products Pain Pract. 2015 Feb; 15(2):95-7
Pergolizzi JV, Ben-Joseph R, Chang CL, Hess G.
Predicting medication persistence to buprenorphine transdermal system. Pain Pract. 2015 Feb;15(2):140-9
Vadivelu N, Gowda AM, Urman RD, Jolly S, Kodumudi V, Maria M, Taylor R Jr, Pergolizzi JV Jr.
Ketorolac tromethamine – routes and clinical implications Pain Pract. 2015 Feb;15(2):175-93
Pergolizzi JV, Köknel Talu G, Zmponga G, Erdine S, Taylor R, Ayan B, Raffa RB
Maximizing value in opioid utilization: Is oxycodone immediate release a good option for pain management? Agri. 2015 Jan; 27(1):1-11
Yarlas A, Miller K, Wen W, Lynch SY, Ripa SR, Pergolizzi J, Raffa RB
Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled Trials Pain Pract. 2015 Jan 20
Yarlas A, Miller K, Wen W, Lynch SY, Munera C, Pergolizzi J, Raffa R, Ripa SR.
Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back pain Postgrad Med. 2015 Jan; 127(1):38-45
Pergolizzi JV, Gharibo C, Ho KY
Treatment Considerations for Cancer Pain: A Global Perspective Pain Pract. 2014 Dec 3.
Langley PC, Pergolizzi JV Jr, Taylor R Jr, Ridgway C
Antioxidant and associated capacities of camu (Myrciaria dubia): a systematic review. J Altern Complement Med. 2015 Jan; 21(1):8-14
Daitch D, Daitch J, Novinson D, Frey M, Mitnick C, Pergolizzi J Jr .
Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients Pain Med. 2014 Dec; 15(12):2087-94.
Ciccozzi A, Angeletti C, Guetti C, Pergolizzi J, Angeletti PM, Mariani R, Marinangeli F
Regional anesthesia techniques for carotid surgery: the state of art J Ultrasound. 2014 May 1; 17(3):175-83
Radnovich R, Chapman CR, Gudin JA, Panchal SJ, Webster LR, Pergolizzi JV Jr
Acute pain: effective management requires comprehensive assessment Postgrad Med. 2014 Jul; 126(4):59-72
Taylor R, Raffa RB, Pergolizzi JV.
Opioid formulations with sequestered naltrexone: a perspective review Ther Adv Drug Saf. 2014 Jun; 5(3):129-37.
Raffa RB, Haidery M, Huang HM, Kalladeen K, Lockstein DE, Ono H, Shope MJ, Sowunmi OA, Tran JK, Pergolizzi JV Jr
The clinical analgesic efficacy of buprenorphine J Clin Pharm Ther. 2014 Dec; 39(6):577-83
Raffa RB, Gudin JA, Nalamachu S, Pergolizzi JV Jr
‘Selective’ COX-1 or COX-2 NSAIDs: time to change a misleading measure J Clin Pharm Ther. 2014 Oct; 39(5):455-6
Galia E, Williams Y, Van Hove B, Pergolizzi J, Etropolski M, Vorsanger G
Evaluation of the tamper-resistant properties of tapentadol extended-release tablets: results of in vitro laboratory analyses J Opioid Manag. 2014 May-Jun; 10(3):149-58
Nalamachu S, Pergolizzi JV, Raffa RB, Lakkireddy DR, Taylor R Jr.
Drug-drug interaction between NSAIDS and low-dose aspirin: a focus on cardiovascular and GI toxicity Expert Opin Drug Saf. 2014 Jul; 13(7):903-17
DOI:10.1517/14740338.2014.924924
Müller-Schwefe G, Ahlbeck K, Aldington D, Alon E, Coaccioli S, Coluzzi F, Huygen F, Jaksch W, Kalso E, Kocot-Kępska M, Kress HG, Mangas AC, Ferri CM, Morlion B, Nicolaou A, Hernández CP, Pergolizzi J, Schäfer M, and Sichère P
Pain in the cancer patient: different pain characteristics CHANGE pharmacological treatment requirements Curr Med Res Opin. 2014 Sep; 30(9):1895-908
DOI:10.1185/03007995.2014.925439
Nalamachu SR, Pergolizzi J, Taylor R Jr, Slatkin NE, Barrett AC, Yu J, Bortey E, Paterson C, Forbes WP
Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials Pain Pract. 2014 May 10
Antor MA, Uribe AA, Erminy-Falcon N, Werner JG, Candiotti KA, Pergolizzi JV and Bergese SD
The effect of transdermal scopolamine for the prevention of postoperative nausea and vomiting Front. Pharmacol., 09 April 2014
Raffa RB, Pergolizzi JV Jr
A modern analgesics pain ‘pyramid’ J Clin Pharm Ther. 2014 Feb; 39(1):4-6
Miller K, Yarlas A, Wen W, Dain B, Lynch SY, Ripa SR, Pergolizzi JV Jr, Raffa R.
The impact of buprenorphine transdermal delivery system on activities of daily living among patients with chronic low back pain: an application of the international classification of functioning, disability and health Clin J Pain. 2014 Dec; 30(12):1015-22
DOI:10.1097/AJP.0000000000000068
Pergolizzi JV, Pappagallo M, LeQuang J, Labhsetwar S, Taylor R.
New health care measures: emphasis on better management of postsurgical pain and postoperative nausea and vomiting Hosp Pract (1995). 2014 Feb; 42(1):65-74
Pergolizzi JV Jr, Raffa RB, Taylor R Jr.
Treating acute pain in light of the chronification of pain Pain Manag Nurs. 2014 Mar; 15(1):380-90
Taylor R Jr, Pergolizzi JV, Raffa RB, Nalamachu S, Balestrieri PJ
Pain and obesity in the older adult Curr Pharm Des. 2014; 20(38):6037-41
Pergolizzi JV Jr, Taylor R Jr, Raffa RB, Nalamachu S, Chopra M.
Fast-Acting Sublingual Zolpidem for Middle-of-the-Night Wakefulness Sleep Disord. 2014; 2014:527109
Pergolizzi JV Jr, Ma L, Foster DR, Overholser BR, Sowinski KM, Taylor R Jr, Summers KH
The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients J Manag Care Spec Pharm. 2014 May; 20(5):467-76
Pergolizzi JV Jr, Ben-Joseph R, Chang CL, Hess G.
US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system Curr Med Res Opin. 2014 Aug; 30(8):1579-87
DOI:10.1185/03007995.2014.901941
Vadivelu N, Gowda AM, Urman RD, Jolly S, Kodumudi V, Maria M, Taylor R Jr, Pergolizzi J.
Ketorolac tromethamine – routes and clinical implications Pain Pract. 2015 Feb; 15(2):175-93